Reuters logo
5 个月内
BRIEF-Protagonist Therapeutics Q4 net loss per share $0.67
2017年3月7日 / 晚上9点23分 / 5 个月内

BRIEF-Protagonist Therapeutics Q4 net loss per share $0.67

1 分钟阅读

March 7 (Reuters) - Protagonist Therapeutics Inc:

* Protagonist Therapeutics reports fourth quarter and year-end 2016 financial results

* Qtrly net loss per share attributable to common stockholders $0.67

* Company reported net loss of $11.2 million for Q4 2016, as compared to a net loss of $5.5 million for Q4 2015

* Protagonist Therapeutics Inc- "increase in net loss was driven primarily by research and development expenses related to PTG-100 clinical trials" Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below